Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring-guided piperacillin-tazobactam in febrile neutropenia
2016-002388-33Phase 4Terminated
- Sponsor
- Friedrich Schiller University Jena
- Start
- Aug 2016
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of piperacillin + tazobactam in bacterial disease (2 arms), sponsored by Friedrich Schiller University Jena. Primary endpoint: Stable fever recovery. Started Aug 2016; status: terminated.
02
Drugs
piperacillin + tazobactam
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2016-002388-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002388-33.